{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Vor Biopharma Inc."},"Symbol":{"label":"Symbol","value":"VOR"},"Address":{"label":"Address","value":"100 CAMBRIDGEPARK DRIVE,SUITE 101, CAMBRIDGE, Massachusetts, 02140, United States"},"Phone":{"label":"Phone","value":"+1 617 655-6580"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33."},"CompanyUrl":{"label":"Company Url","value":"https://www.vorbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Bob Ang","title":"President, Chief Executive Officer & Director"},{"name":"Eyal C. Attar","title":"Chief Medical Officer"},{"name":"Tirtha Chakraborty","title":"Chief Scientific Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}